Rosie Cooper – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Rosie Cooper on 2016-07-12.

To ask the Secretary of State for Health, what assessment NICE has made of the need for clinical guidelines on hidradenitis suppurativa.

Nicola Blackwood

The National Institute for Health and Care Excellence (NICE) has advised that it has not made any assessment of the need to develop a clinical guideline on the care of people with hidradenitis suppurativa, nor has it been asked to develop a clinical guideline on this condition.

NICE published technology appraisal guidance on adalimumab (Humira) for treating moderate to severe hidradenitis suppurativa (TA392) on 22 June 2016, which recommends its use. Commissioners now have three months in which to put in place funding arrangements.